

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.64120277 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.64120277 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.20275349 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.20275349 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.68715041 |
| 6 | glyoxylate metabolic process (GO:0046487) | 6.07239670 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 5.87836338 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.81705954 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.81705954 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.81705954 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.51194784 |
| 12 | cysteine metabolic process (GO:0006534) | 5.49893226 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.46530713 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.46148515 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.11562432 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.06695474 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.06112107 |
| 18 | lysine catabolic process (GO:0006554) | 4.83755365 |
| 19 | lysine metabolic process (GO:0006553) | 4.83755365 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82742923 |
| 21 | aromatic amino acid family metabolic process (GO:0009072) | 4.82296998 |
| 22 | omega-hydroxylase P450 pathway (GO:0097267) | 4.79817247 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 4.74844200 |
| 24 | drug transmembrane transport (GO:0006855) | 4.69516564 |
| 25 | bile acid metabolic process (GO:0008206) | 4.68737220 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.62466713 |
| 27 | urea cycle (GO:0000050) | 4.61817211 |
| 28 | urea metabolic process (GO:0019627) | 4.61817211 |
| 29 | cellular ketone body metabolic process (GO:0046950) | 4.53435127 |
| 30 | tyrosine metabolic process (GO:0006570) | 4.52909424 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 4.47801312 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.44155168 |
| 33 | urate metabolic process (GO:0046415) | 4.41926671 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.40835596 |
| 35 | protein carboxylation (GO:0018214) | 4.40835596 |
| 36 | alpha-amino acid catabolic process (GO:1901606) | 4.40078579 |
| 37 | drug catabolic process (GO:0042737) | 4.37906760 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 4.33815006 |
| 39 | short-chain fatty acid metabolic process (GO:0046459) | 4.32345079 |
| 40 | amino-acid betaine metabolic process (GO:0006577) | 4.31494566 |
| 41 | regulation of fibrinolysis (GO:0051917) | 4.30476023 |
| 42 | complement activation, alternative pathway (GO:0006957) | 4.21084148 |
| 43 | coenzyme catabolic process (GO:0009109) | 4.20004361 |
| 44 | indolalkylamine metabolic process (GO:0006586) | 4.18758197 |
| 45 | glutamate metabolic process (GO:0006536) | 4.17265461 |
| 46 | cellular amino acid catabolic process (GO:0009063) | 4.14375140 |
| 47 | ethanol metabolic process (GO:0006067) | 4.14259750 |
| 48 | regulation of protein activation cascade (GO:2000257) | 4.13985576 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 4.12612246 |
| 50 | cellular glucuronidation (GO:0052695) | 4.12306619 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 4.11504911 |
| 52 | low-density lipoprotein particle clearance (GO:0034383) | 4.08908366 |
| 53 | cellular biogenic amine catabolic process (GO:0042402) | 4.07994288 |
| 54 | amine catabolic process (GO:0009310) | 4.07994288 |
| 55 | acetyl-CoA metabolic process (GO:0006084) | 4.07387558 |
| 56 | diacylglycerol metabolic process (GO:0046339) | 4.05550594 |
| 57 | regulation of cholesterol esterification (GO:0010872) | 4.05326272 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.03676340 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.03676340 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.01511996 |
| 61 | phospholipid homeostasis (GO:0055091) | 3.99328646 |
| 62 | cellular modified amino acid catabolic process (GO:0042219) | 3.98137834 |
| 63 | triglyceride catabolic process (GO:0019433) | 3.98079910 |
| 64 | blood coagulation, intrinsic pathway (GO:0007597) | 3.97923460 |
| 65 | intestinal absorption (GO:0050892) | 3.97025982 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 3.96440276 |
| 67 | negative regulation of sterol transport (GO:0032372) | 3.96440276 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 3.95873390 |
| 69 | phenylpropanoid metabolic process (GO:0009698) | 3.95434521 |
| 70 | ketone body metabolic process (GO:1902224) | 3.94307688 |
| 71 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.91189750 |
| 72 | ethanol oxidation (GO:0006069) | 3.89822604 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 3.89291275 |
| 74 | very long-chain fatty acid metabolic process (GO:0000038) | 3.87660992 |
| 75 | aldehyde catabolic process (GO:0046185) | 3.87343704 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.86534107 |
| 77 | fibrinolysis (GO:0042730) | 3.85852944 |
| 78 | exogenous drug catabolic process (GO:0042738) | 3.85733866 |
| 79 | regulation of complement activation (GO:0030449) | 3.85680121 |
| 80 | heme transport (GO:0015886) | 3.85508192 |
| 81 | neutral lipid catabolic process (GO:0046461) | 3.83676421 |
| 82 | acylglycerol catabolic process (GO:0046464) | 3.83676421 |
| 83 | plasma lipoprotein particle remodeling (GO:0034369) | 3.83404053 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 3.83404053 |
| 85 | macromolecular complex remodeling (GO:0034367) | 3.83404053 |
| 86 | benzene-containing compound metabolic process (GO:0042537) | 3.82755018 |
| 87 | plasma lipoprotein particle clearance (GO:0034381) | 3.81097048 |
| 88 | drug transport (GO:0015893) | 3.80785508 |
| 89 | fatty acid elongation (GO:0030497) | 3.79972539 |
| 90 | glucuronate metabolic process (GO:0019585) | 3.79349922 |
| 91 | uronic acid metabolic process (GO:0006063) | 3.79349922 |
| 92 | phospholipid efflux (GO:0033700) | 3.73796524 |
| 93 | protein activation cascade (GO:0072376) | 3.71469455 |
| 94 | glycine metabolic process (GO:0006544) | 3.71404210 |
| 95 | acute-phase response (GO:0006953) | 3.70682614 |
| 96 | organic acid catabolic process (GO:0016054) | 3.70589915 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.70589915 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69380222 |
| 99 | intestinal cholesterol absorption (GO:0030299) | 3.68987421 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.68081336 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.66992798 |
| 102 | response to mercury ion (GO:0046689) | 3.66959963 |
| 103 | fatty acid beta-oxidation (GO:0006635) | 3.64137548 |
| 104 | cholesterol efflux (GO:0033344) | 3.59520739 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.57216375 |
| 106 | cofactor catabolic process (GO:0051187) | 3.56836787 |
| 107 | fatty acid oxidation (GO:0019395) | 3.56810603 |
| 108 | fatty acid homeostasis (GO:0055089) | 3.55728905 |
| 109 | monocarboxylic acid catabolic process (GO:0072329) | 3.53407080 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.53065211 |
| 111 | imidazole-containing compound metabolic process (GO:0052803) | 3.52470312 |
| 112 | plasma lipoprotein particle organization (GO:0071827) | 3.51868440 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 3.50933713 |
| 114 | fatty acid catabolic process (GO:0009062) | 3.50309851 |
| 115 | regulation of plasminogen activation (GO:0010755) | 3.50182641 |
| 116 | lipid oxidation (GO:0034440) | 3.49814488 |
| 117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48450638 |
| 118 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48450638 |
| 119 | flavonoid metabolic process (GO:0009812) | 3.48102390 |
| 120 | negative regulation of blood coagulation (GO:0030195) | 3.47764118 |
| 121 | negative regulation of hemostasis (GO:1900047) | 3.47764118 |
| 122 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.47157850 |
| 123 | drug metabolic process (GO:0017144) | 3.46564356 |
| 124 | arginine metabolic process (GO:0006525) | 3.45414538 |
| 125 | complement activation (GO:0006956) | 3.45125182 |
| 126 | cholesterol homeostasis (GO:0042632) | 3.44401055 |
| 127 | sterol homeostasis (GO:0055092) | 3.40754361 |
| 128 | plasma lipoprotein particle assembly (GO:0034377) | 3.40468229 |
| 129 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.38619279 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 3.36835882 |
| 131 | primary alcohol catabolic process (GO:0034310) | 3.36414414 |
| 132 | polyketide metabolic process (GO:0030638) | 3.35812907 |
| 133 | doxorubicin metabolic process (GO:0044598) | 3.35812907 |
| 134 | daunorubicin metabolic process (GO:0044597) | 3.35812907 |
| 135 | oxidative demethylation (GO:0070989) | 3.35492852 |
| 136 | biotin metabolic process (GO:0006768) | 3.34217455 |
| 137 | primary alcohol metabolic process (GO:0034308) | 3.33108798 |
| 138 | negative regulation of coagulation (GO:0050819) | 3.27334189 |
| 139 | regulation of humoral immune response (GO:0002920) | 3.16163207 |
| 140 | protein-lipid complex assembly (GO:0065005) | 3.14175230 |
| 141 | negative regulation of wound healing (GO:0061045) | 3.13651544 |
| 142 | positive regulation of blood coagulation (GO:0030194) | 3.11411586 |
| 143 | positive regulation of hemostasis (GO:1900048) | 3.11411586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.33225272 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.18927726 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.98638895 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.79691257 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.66338323 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.12311464 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85295201 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.48594082 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.38166730 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.2274482 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85315196 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85160430 |
| 13 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66719656 |
| 14 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62789199 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50627521 |
| 16 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42148314 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38386402 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35995531 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34274862 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.33491594 |
| 21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.29710963 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27872857 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.27667798 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23022723 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21858101 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14676453 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14031863 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11410051 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06927486 |
| 30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05132857 |
| 31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05132857 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00172666 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99424497 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96985560 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96950223 |
| 36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95973239 |
| 37 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89805504 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89566688 |
| 39 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88835355 |
| 40 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88639200 |
| 41 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86532803 |
| 42 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86312658 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.85263504 |
| 44 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84863838 |
| 45 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84567332 |
| 46 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.83791694 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83246848 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83087788 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82061338 |
| 50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81792245 |
| 51 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80156773 |
| 52 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80141109 |
| 53 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79308258 |
| 54 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.78471512 |
| 55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77602647 |
| 56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.76887898 |
| 57 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.76863932 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75815057 |
| 59 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.75812143 |
| 60 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.75767804 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.74512340 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74272373 |
| 63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73716268 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73534325 |
| 65 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73441744 |
| 66 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.72321239 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72036739 |
| 68 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71877750 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71653339 |
| 70 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.70483025 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70304269 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.69653221 |
| 73 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.69049670 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.68785923 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.68747549 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.68232046 |
| 77 | CJUN_26792858_Chip-Seq_BT549_Human | 0.67466484 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66981965 |
| 79 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66582674 |
| 80 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66535857 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.66455035 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.65145243 |
| 83 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.64779026 |
| 84 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64562912 |
| 85 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.64530100 |
| 86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64498281 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63769087 |
| 88 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.62950717 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62741066 |
| 90 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.62516613 |
| 91 | RXR_22108803_ChIP-Seq_LS180_Human | 0.61609339 |
| 92 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.60873760 |
| 93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60340156 |
| 94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60229054 |
| 95 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.60168638 |
| 96 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.60168638 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59763658 |
| 98 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.59560849 |
| 99 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.59353014 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.58575751 |
| 101 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58531110 |
| 102 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.58408734 |
| 103 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58089250 |
| 104 | NCOR_22424771_ChIP-Seq_293T_Human | 0.57971750 |
| 105 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.57908463 |
| 106 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.57468162 |
| 107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.57416000 |
| 108 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.57250460 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.56817975 |
| 110 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.56238001 |
| 111 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.56238001 |
| 112 | GATA1_22025678_ChIP-Seq_K562_Human | 0.56179783 |
| 113 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.55722090 |
| 114 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.55377345 |
| 115 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.54920578 |
| 116 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.54675277 |
| 117 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53767081 |
| 118 | GATA1_19941826_ChIP-Seq_K562_Human | 0.53516901 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.53252032 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.52669963 |
| 121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.51693338 |
| 122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.51681853 |
| 123 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.50604288 |
| 124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.50447902 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.50327062 |
| 126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.50159344 |
| 127 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.50018350 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.49563436 |
| 129 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49236001 |
| 130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.48937108 |
| 131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48043255 |
| 132 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.47852012 |
| 133 | VDR_22108803_ChIP-Seq_LS180_Human | 0.47362741 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.47325673 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47242908 |
| 136 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47229925 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.46239285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.81724325 |
| 2 | MP0005360_urolithiasis | 7.68525758 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.87247857 |
| 4 | MP0005365_abnormal_bile_salt | 5.62962436 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.89894682 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.40396886 |
| 7 | MP0003252_abnormal_bile_duct | 3.67605869 |
| 8 | MP0003195_calcinosis | 3.57839406 |
| 9 | MP0005332_abnormal_amino_acid | 3.22542229 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.95665243 |
| 11 | MP0009840_abnormal_foam_cell | 2.75230363 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.73058492 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.64758808 |
| 14 | MP0005083_abnormal_biliary_tract | 2.52361186 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.14631441 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.12419698 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.06112875 |
| 18 | MP0005451_abnormal_body_composition | 1.98409494 |
| 19 | MP0004043_abnormal_pH_regulation | 1.95230947 |
| 20 | MP0000609_abnormal_liver_physiology | 1.82616609 |
| 21 | MP0009643_abnormal_urine_homeostasis | 1.77749110 |
| 22 | MP0003868_abnormal_feces_composition | 1.75618275 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65157150 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.61061530 |
| 25 | MP0001764_abnormal_homeostasis | 1.54055621 |
| 26 | MP0005375_adipose_tissue_phenotype | 1.42573228 |
| 27 | MP0005409_darkened_coat_color | 1.42028371 |
| 28 | MP0009115_abnormal_fat_cell | 1.36963461 |
| 29 | MP0003690_abnormal_glial_cell | 1.36223721 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.35810886 |
| 31 | MP0003186_abnormal_redox_activity | 1.29249304 |
| 32 | MP0003879_abnormal_hair_cell | 1.28501123 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.24673258 |
| 34 | MP0002132_abnormal_respiratory_system | 1.22396233 |
| 35 | MP0000920_abnormal_myelination | 1.21135611 |
| 36 | MP0000604_amyloidosis | 1.19105580 |
| 37 | MP0003329_amyloid_beta_deposits | 1.16348263 |
| 38 | MP0000566_synostosis | 1.12854347 |
| 39 | MP0009697_abnormal_copulation | 1.12347871 |
| 40 | MP0002970_abnormal_white_adipose | 1.09010328 |
| 41 | MP0004272_abnormal_basement_membrane | 1.03743680 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.03562229 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.02346715 |
| 44 | MP0001756_abnormal_urination | 1.01892863 |
| 45 | MP0001661_extended_life_span | 1.01819210 |
| 46 | MP0005408_hypopigmentation | 1.01175926 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.00545812 |
| 48 | MP0003011_delayed_dark_adaptation | 1.00271761 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 0.97863936 |
| 50 | MP0001765_abnormal_ion_homeostasis | 0.90304180 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 0.90279265 |
| 52 | MP0003959_abnormal_lean_body | 0.90258113 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 0.89357804 |
| 54 | MP0000598_abnormal_liver_morphology | 0.88653947 |
| 55 | MP0005647_abnormal_sex_gland | 0.85351987 |
| 56 | MP0000003_abnormal_adipose_tissue | 0.85089750 |
| 57 | MP0009642_abnormal_blood_homeostasis | 0.83478622 |
| 58 | MP0002136_abnormal_kidney_physiology | 0.83324815 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.82769377 |
| 60 | MP0009764_decreased_sensitivity_to | 0.82547974 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.81839844 |
| 62 | MP0004147_increased_porphyrin_level | 0.80390687 |
| 63 | MP0002822_catalepsy | 0.78562831 |
| 64 | MP0005670_abnormal_white_adipose | 0.78447844 |
| 65 | MP0009763_increased_sensitivity_to | 0.78201830 |
| 66 | MP0009765_abnormal_xenobiotic_induced | 0.78031086 |
| 67 | MP0010386_abnormal_urinary_bladder | 0.75002622 |
| 68 | MP0008469_abnormal_protein_level | 0.73444916 |
| 69 | MP0005535_abnormal_body_temperature | 0.72853060 |
| 70 | MP0004885_abnormal_endolymph | 0.70880271 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 0.70688967 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.69255149 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 0.65789454 |
| 74 | MP0005376_homeostasis/metabolism_phenot | 0.65229441 |
| 75 | MP0002971_abnormal_brown_adipose | 0.64493944 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.64480208 |
| 77 | MP0001664_abnormal_digestion | 0.63635334 |
| 78 | MP0005452_abnormal_adipose_tissue | 0.62802810 |
| 79 | MP0001944_abnormal_pancreas_morphology | 0.61674813 |
| 80 | MP0004381_abnormal_hair_follicle | 0.59877838 |
| 81 | MP0000462_abnormal_digestive_system | 0.59874811 |
| 82 | MP0005164_abnormal_response_to | 0.57601574 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.56093502 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.55621680 |
| 85 | MP0002796_impaired_skin_barrier | 0.54124496 |
| 86 | MP0005334_abnormal_fat_pad | 0.53415044 |
| 87 | MP0002254_reproductive_system_inflammat | 0.52476290 |
| 88 | MP0005503_abnormal_tendon_morphology | 0.51187498 |
| 89 | MP0005666_abnormal_adipose_tissue | 0.50881308 |
| 90 | MP0005395_other_phenotype | 0.50860158 |
| 91 | MP0005266_abnormal_metabolism | 0.50258876 |
| 92 | MP0000249_abnormal_blood_vessel | 0.48072052 |
| 93 | MP0006138_congestive_heart_failure | 0.47820513 |
| 94 | MP0000639_abnormal_adrenal_gland | 0.47561579 |
| 95 | MP0002168_other_aberrant_phenotype | 0.45209025 |
| 96 | MP0006082_CNS_inflammation | 0.44915765 |
| 97 | MP0000538_abnormal_urinary_bladder | 0.44361361 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.44210093 |
| 99 | MP0008874_decreased_physiological_sensi | 0.43538014 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.43073736 |
| 101 | MP0003866_abnormal_defecation | 0.41538755 |
| 102 | MP0004142_abnormal_muscle_tone | 0.40767606 |
| 103 | MP0008873_increased_physiological_sensi | 0.40441358 |
| 104 | MP0004883_abnormal_blood_vessel | 0.40263596 |
| 105 | MP0006035_abnormal_mitochondrial_morpho | 0.40170892 |
| 106 | MP0003632_abnormal_nervous_system | 0.39774032 |
| 107 | MP0005023_abnormal_wound_healing | 0.39692005 |
| 108 | MP0003953_abnormal_hormone_level | 0.39665654 |
| 109 | MP0003724_increased_susceptibility_to | 0.39286543 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.39004916 |
| 111 | MP0002229_neurodegeneration | 0.38950598 |
| 112 | MP0009672_abnormal_birth_weight | 0.38464214 |
| 113 | MP0004130_abnormal_muscle_cell | 0.38412681 |
| 114 | MP0003718_maternal_effect | 0.37087826 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.36950345 |
| 116 | MP0003075_altered_response_to | 0.35484017 |
| 117 | MP0003300_gastrointestinal_ulcer | 0.34458339 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.34342493 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.34309519 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.34287582 |
| 121 | MP0005448_abnormal_energy_balance | 0.33868916 |
| 122 | MP0001177_atelectasis | 0.33836132 |
| 123 | MP0001663_abnormal_digestive_system | 0.32931574 |
| 124 | MP0004264_abnormal_extraembryonic_tissu | 0.32755027 |
| 125 | MP0002928_abnormal_bile_duct | 0.31600489 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.31501618 |
| 127 | MP0003705_abnormal_hypodermis_morpholog | 0.30655807 |
| 128 | MP0005166_decreased_susceptibility_to | 0.30124819 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.29764836 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.29387176 |
| 131 | MP0000579_abnormal_nail_morphology | 0.28807764 |
| 132 | MP0005551_abnormal_eye_electrophysiolog | 0.28564101 |
| 133 | MP0008872_abnormal_physiological_respon | 0.27936331 |
| 134 | MP0003631_nervous_system_phenotype | 0.27392572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.92404085 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.81903144 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.95728719 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.65011513 |
| 5 | Xanthomatosis (HP:0000991) | 5.41468501 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.15079524 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.10292118 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.59669807 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.45788238 |
| 10 | Glomerulonephritis (HP:0000099) | 4.38516586 |
| 11 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.33900137 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.18980902 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.18980902 |
| 14 | Hyperammonemia (HP:0001987) | 4.18465311 |
| 15 | Ketosis (HP:0001946) | 4.18288108 |
| 16 | Hyperglycinuria (HP:0003108) | 4.16484620 |
| 17 | Hyperglycinemia (HP:0002154) | 4.06234510 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.01062111 |
| 19 | Complement deficiency (HP:0004431) | 4.00533707 |
| 20 | Fat malabsorption (HP:0002630) | 3.91455684 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.83143527 |
| 22 | Joint hemorrhage (HP:0005261) | 3.78959164 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.70831472 |
| 24 | Epidermoid cyst (HP:0200040) | 3.67279511 |
| 25 | Hemorrhage of the eye (HP:0011885) | 3.65192021 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63265467 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.49805607 |
| 28 | Gout (HP:0001997) | 3.49629600 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.48808731 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.37418916 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.36243502 |
| 32 | Ketoacidosis (HP:0001993) | 3.34581492 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.25966482 |
| 34 | Nephritis (HP:0000123) | 3.24681547 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.17712618 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 3.17344652 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 3.12723986 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09929364 |
| 39 | Alkalosis (HP:0001948) | 3.07865876 |
| 40 | Steatorrhea (HP:0002570) | 3.04537367 |
| 41 | Vascular calcification (HP:0004934) | 3.02570787 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.95098788 |
| 43 | Hyperbilirubinemia (HP:0002904) | 2.93893464 |
| 44 | Hypercholesterolemia (HP:0003124) | 2.88932731 |
| 45 | Dicarboxylic aciduria (HP:0003215) | 2.85464375 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.85464375 |
| 47 | Metabolic acidosis (HP:0001942) | 2.82584880 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.82479411 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.77817966 |
| 50 | Abnormality of complement system (HP:0005339) | 2.73925435 |
| 51 | Potter facies (HP:0002009) | 2.68426312 |
| 52 | Facial shape deformation (HP:0011334) | 2.68426312 |
| 53 | Lethargy (HP:0001254) | 2.66866095 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.64716455 |
| 55 | Hypokalemic alkalosis (HP:0001949) | 2.61486902 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.58323073 |
| 57 | Proximal tubulopathy (HP:0000114) | 2.57979812 |
| 58 | Increased purine levels (HP:0004368) | 2.56425902 |
| 59 | Hyperuricemia (HP:0002149) | 2.56425902 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.54008684 |
| 61 | Metabolic alkalosis (HP:0200114) | 2.53784136 |
| 62 | Increased circulating renin level (HP:0000848) | 2.53429597 |
| 63 | Malnutrition (HP:0004395) | 2.53329341 |
| 64 | Rickets (HP:0002748) | 2.53322208 |
| 65 | Abnormality of renin-angiotensin system (HP:0000847) | 2.52537675 |
| 66 | Irritability (HP:0000737) | 2.49903721 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.49612861 |
| 68 | Glycosuria (HP:0003076) | 2.49612861 |
| 69 | Enlarged kidneys (HP:0000105) | 2.47716627 |
| 70 | Cerebral edema (HP:0002181) | 2.45413124 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39870951 |
| 72 | Hypoglycemic seizures (HP:0002173) | 2.39798577 |
| 73 | Hypertriglyceridemia (HP:0002155) | 2.39718620 |
| 74 | Hyperaldosteronism (HP:0000859) | 2.37559391 |
| 75 | Vomiting (HP:0002013) | 2.35646656 |
| 76 | Spastic paraparesis (HP:0002313) | 2.34127270 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.32213134 |
| 78 | Increased serum pyruvate (HP:0003542) | 2.26852277 |
| 79 | Abnormality of proline metabolism (HP:0010907) | 2.23722996 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.23722996 |
| 81 | Hypophosphatemic rickets (HP:0004912) | 2.20284142 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.20082943 |
| 83 | Acanthocytosis (HP:0001927) | 2.19542595 |
| 84 | Abnormal gallbladder physiology (HP:0012438) | 2.19219915 |
| 85 | Cholecystitis (HP:0001082) | 2.19219915 |
| 86 | Hyperactive renin-angiotensin system (HP:0000841) | 2.19051849 |
| 87 | Abnormality of glycolysis (HP:0004366) | 2.17651031 |
| 88 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.14747944 |
| 89 | Gingival bleeding (HP:0000225) | 2.14460538 |
| 90 | Spontaneous abortion (HP:0005268) | 2.14189682 |
| 91 | Abnormality of carpal bone ossification (HP:0006257) | 2.10788386 |
| 92 | Confusion (HP:0001289) | 2.09958572 |
| 93 | Myocardial infarction (HP:0001658) | 2.09275828 |
| 94 | Neonatal onset (HP:0003623) | 2.07783967 |
| 95 | Abnormality of vitamin metabolism (HP:0100508) | 2.07729875 |
| 96 | Hyperphosphaturia (HP:0003109) | 2.07111698 |
| 97 | Skin nodule (HP:0200036) | 2.05968090 |
| 98 | Focal segmental glomerulosclerosis (HP:0000097) | 2.05073291 |
| 99 | Systemic lupus erythematosus (HP:0002725) | 2.04936960 |
| 100 | Opisthotonus (HP:0002179) | 2.04881649 |
| 101 | Hypomagnesemia (HP:0002917) | 2.04867581 |
| 102 | Brushfield spots (HP:0001088) | 2.04258190 |
| 103 | Hypochromic microcytic anemia (HP:0004840) | 2.04038844 |
| 104 | Pancreatitis (HP:0001733) | 2.03259901 |
| 105 | Osteomalacia (HP:0002749) | 2.03090503 |
| 106 | Cholelithiasis (HP:0001081) | 2.02929442 |
| 107 | Spastic diplegia (HP:0001264) | 2.01082087 |
| 108 | Nausea (HP:0002018) | 2.00277268 |
| 109 | Amyloidosis (HP:0011034) | 1.99332984 |
| 110 | Neurofibrillary tangles (HP:0002185) | 1.98658929 |
| 111 | Abnormal tarsal ossification (HP:0008369) | 1.98526728 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97775867 |
| 113 | Mitral stenosis (HP:0001718) | 1.96555196 |
| 114 | Abnormal urine output (HP:0012590) | 1.96118633 |
| 115 | Late onset (HP:0003584) | 1.95794829 |
| 116 | Abnormality of chloride homeostasis (HP:0011422) | 1.95044332 |
| 117 | Hypokalemia (HP:0002900) | 1.94369880 |
| 118 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93726839 |
| 119 | Renal tubular acidosis (HP:0001947) | 1.92051203 |
| 120 | Ileus (HP:0002595) | 1.90988799 |
| 121 | Flat acetabular roof (HP:0003180) | 1.90459416 |
| 122 | Abdominal distention (HP:0003270) | 1.89843412 |
| 123 | Hypophosphatemia (HP:0002148) | 1.88014867 |
| 124 | Menorrhagia (HP:0000132) | 1.87892177 |
| 125 | Abnormality of magnesium homeostasis (HP:0004921) | 1.81158298 |
| 126 | Abnormal urine phosphate concentration (HP:0012599) | 1.79360853 |
| 127 | Glomerulosclerosis (HP:0000096) | 1.76269766 |
| 128 | Acanthosis nigricans (HP:0000956) | 1.74496313 |
| 129 | Elevated alkaline phosphatase (HP:0003155) | 1.74319817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.13764005 |
| 2 | OXSR1 | 4.96142890 |
| 3 | STK39 | 4.84010221 |
| 4 | WNK4 | 4.26185703 |
| 5 | LMTK2 | 3.61963099 |
| 6 | WNK3 | 3.21303522 |
| 7 | RIPK1 | 3.19406340 |
| 8 | EPHA2 | 2.80949353 |
| 9 | FGFR4 | 2.72816386 |
| 10 | SIK1 | 2.57105131 |
| 11 | EPHB1 | 2.53381826 |
| 12 | INSRR | 2.49824887 |
| 13 | ERBB4 | 2.37215336 |
| 14 | TRIB3 | 2.24940038 |
| 15 | MET | 2.13772788 |
| 16 | ACVR1B | 2.13096333 |
| 17 | PKN1 | 2.00187756 |
| 18 | ERN1 | 1.93446923 |
| 19 | TAOK3 | 1.87088522 |
| 20 | FGFR3 | 1.86322142 |
| 21 | MST1R | 1.78902239 |
| 22 | FGFR2 | 1.70004286 |
| 23 | EPHB2 | 1.67382326 |
| 24 | MAPK15 | 1.62694097 |
| 25 | PBK | 1.57591466 |
| 26 | TBK1 | 1.46976802 |
| 27 | PRKG2 | 1.46616914 |
| 28 | PIK3CG | 1.35329757 |
| 29 | SGK494 | 1.30225583 |
| 30 | SGK223 | 1.30225583 |
| 31 | ABL2 | 1.26537250 |
| 32 | WNK1 | 1.24693706 |
| 33 | MST4 | 1.24359458 |
| 34 | BCR | 1.22101460 |
| 35 | DDR2 | 1.19959802 |
| 36 | CAMK1D | 1.17144918 |
| 37 | BMX | 1.15443157 |
| 38 | RET | 1.15101644 |
| 39 | ICK | 1.14736199 |
| 40 | FER | 1.12519538 |
| 41 | CSNK1G1 | 1.11980918 |
| 42 | CSNK1G3 | 1.10315391 |
| 43 | MAPK11 | 1.06803780 |
| 44 | NLK | 1.05482875 |
| 45 | IRAK3 | 1.02786949 |
| 46 | PINK1 | 0.99562047 |
| 47 | CSNK1A1L | 0.99330674 |
| 48 | MYLK | 0.98867245 |
| 49 | CAMK2G | 0.96767651 |
| 50 | TAOK2 | 0.95759796 |
| 51 | MAP3K1 | 0.89352539 |
| 52 | PRKCQ | 0.86932625 |
| 53 | KSR2 | 0.86666413 |
| 54 | PDGFRA | 0.86632276 |
| 55 | IKBKE | 0.86460131 |
| 56 | MAP2K4 | 0.85352403 |
| 57 | IRAK2 | 0.85159546 |
| 58 | PRKAA2 | 0.82862856 |
| 59 | GRK6 | 0.82211109 |
| 60 | CSNK1G2 | 0.81953672 |
| 61 | GSK3A | 0.80901601 |
| 62 | TNIK | 0.80696251 |
| 63 | MAP2K1 | 0.78776845 |
| 64 | LATS1 | 0.78161123 |
| 65 | STK24 | 0.77243718 |
| 66 | TESK2 | 0.76817851 |
| 67 | PTK6 | 0.76657114 |
| 68 | KDR | 0.75599155 |
| 69 | TIE1 | 0.75269393 |
| 70 | NTRK1 | 0.73391765 |
| 71 | IRAK1 | 0.71926414 |
| 72 | CAMK1 | 0.71652682 |
| 73 | NEK6 | 0.71132172 |
| 74 | PTK2 | 0.70577355 |
| 75 | MAP3K7 | 0.70566887 |
| 76 | EPHA4 | 0.70382561 |
| 77 | NTRK3 | 0.69815550 |
| 78 | TESK1 | 0.69115038 |
| 79 | CAMK2B | 0.68091612 |
| 80 | CAMK1G | 0.67937489 |
| 81 | CSK | 0.67497197 |
| 82 | MAPKAPK3 | 0.66979650 |
| 83 | STK38L | 0.66248087 |
| 84 | PRKCZ | 0.63095938 |
| 85 | MAP2K6 | 0.62316964 |
| 86 | FGFR1 | 0.61305034 |
| 87 | MAP3K12 | 0.60701664 |
| 88 | PDGFRB | 0.60659654 |
| 89 | CDC42BPA | 0.57989832 |
| 90 | MTOR | 0.57722524 |
| 91 | JAK2 | 0.57668777 |
| 92 | PAK3 | 0.57413509 |
| 93 | YES1 | 0.55419918 |
| 94 | PRKACG | 0.55108908 |
| 95 | STK38 | 0.54983543 |
| 96 | MAP3K3 | 0.54906625 |
| 97 | CAMK2D | 0.54878210 |
| 98 | FRK | 0.54109834 |
| 99 | DYRK1B | 0.53186588 |
| 100 | * PDPK1 | 0.52871733 |
| 101 | MAP2K2 | 0.52847733 |
| 102 | ERBB2 | 0.50530025 |
| 103 | MAPK7 | 0.50343605 |
| 104 | PRKCE | 0.48644340 |
| 105 | FLT3 | 0.47499548 |
| 106 | PRKAA1 | 0.47394885 |
| 107 | CSF1R | 0.47313716 |
| 108 | MAPK4 | 0.47120885 |
| 109 | DAPK2 | 0.46530975 |
| 110 | PIK3CA | 0.45576702 |
| 111 | GRK1 | 0.44179274 |
| 112 | MAP3K14 | 0.43560410 |
| 113 | PRKD1 | 0.43041118 |
| 114 | PDK2 | 0.42449001 |
| 115 | PKN2 | 0.41580005 |
| 116 | STK3 | 0.41156528 |
| 117 | CDK6 | 0.41118228 |
| 118 | SGK3 | 0.41065515 |
| 119 | MAPK12 | 0.40831187 |
| 120 | MAP3K2 | 0.40341845 |
| 121 | SRC | 0.39434293 |
| 122 | ROCK2 | 0.39338081 |
| 123 | TYK2 | 0.37431614 |
| 124 | LATS2 | 0.36338857 |
| 125 | IGF1R | 0.35821118 |
| 126 | FGR | 0.35716384 |
| 127 | MARK2 | 0.35410094 |
| 128 | CDK9 | 0.34967828 |
| 129 | CAMK2A | 0.34694903 |
| 130 | STK16 | 0.34608401 |
| 131 | PRKCA | 0.33867947 |
| 132 | TAOK1 | 0.32910497 |
| 133 | JAK1 | 0.32239568 |
| 134 | TYRO3 | 0.31625525 |
| 135 | PRKCG | 0.29795077 |
| 136 | PRKACA | 0.29770186 |
| 137 | UHMK1 | 0.27126699 |
| 138 | ITK | 0.24880605 |
| 139 | PRKACB | 0.24835000 |
| 140 | ARAF | 0.24262286 |
| 141 | EPHA3 | 0.23265609 |
| 142 | SGK2 | 0.22718855 |
| 143 | PRKG1 | 0.21707035 |
| 144 | ABL1 | 0.21532736 |
| 145 | PRKCH | 0.21278979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.87474746 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21780582 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02273169 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.79724583 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78093845 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.63910718 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63761400 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63424083 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63189018 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.61783725 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53960160 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44812843 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.44284309 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24324872 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.22191254 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.19783998 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.12423203 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.12202488 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.10248882 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.03782158 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98680540 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94467697 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92408769 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81179632 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78745133 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78070270 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77680009 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74323713 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58525997 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58432053 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54622223 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53042884 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.52198894 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51517521 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.48447456 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43423052 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42621647 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34838972 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31694167 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30885447 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30267640 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25158599 |
| 43 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24643618 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.21725209 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21569225 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20894514 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19499796 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14729322 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.14338513 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13669085 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11841142 |
| 52 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11513491 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08746624 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07345144 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.99074345 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98963637 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95361062 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86449571 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79465182 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77611118 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.77053817 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69537754 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64024419 |
| 64 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56894354 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54769664 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50451006 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49056665 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46854527 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46808727 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39457595 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32431422 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31906106 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31328160 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26920020 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.25349444 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23931861 |
| 77 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22509006 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.21734470 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20622223 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.16172241 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.14440956 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13023052 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.12992351 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12538509 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.12333650 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.11935055 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11117151 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10657543 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.08783529 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.05462917 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.04124777 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01780104 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01386944 |
| 94 | Protein export_Homo sapiens_hsa03060 | -0.1280786 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1258391 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1253251 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1229718 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.1133989 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0999373 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0899202 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0881617 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0737989 |
| 103 | Lysosome_Homo sapiens_hsa04142 | -0.0699848 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0689192 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0652938 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0540456 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0533257 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0430555 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | -0.0336467 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0253183 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0084296 |

